The pharmaceutical care by clinical pharmacists for a foot injury patient with postoperative MRSA infection
10.12206/j.issn.1006-0111.202102004
- VernacularTitle:临床药师参与1例足部损伤患者术后MRSA感染治疗的药学监护
- Author:
Jingjing LUO
1
;
Xinan WU
1
;
Gang XUE
2
;
Zhengdong XIE
2
;
Jianbo YE
2
;
Chengting RONG
1
Author Information
1. Department of pharmacy.
2. Department of orthopedics, Hefei BOE Hospital, Anhui, Hefei, 230011, China.
- Keywords:
clinical pharmacist;
vancomycin;
MRSA;
pharmaceutical care
- From:
Journal of Pharmaceutical Practice
2022;40(3):286-288
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical pharmacist’s role in drug therapy and monitoring for the patient with postoperative MRSA infection. Methods Clinical pharmacists participated in planning anti-infective treatment, antimicrobial medication selection, identification of high-risk factors for MRSA infection, evaluation of vancomycin efficacy, dosage adjustment using TDM technology, monitoring and management of vancomycin adverse reactions. Results With the pharmaceutical care provided by clinical pharmacists, the patient received effective treatment with minimal vancomycin-related adverse reactions. Conclusion Clinical pharmacists played an important role in accelerating patient recovery by rational and safe medication use.
